JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Anti-Cancer Effects of Green Tea by Either Anti- or Pro-Oxidative Mechanisms
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Anti-Cancer Effects of Green Tea by Either Anti- or Pro-Oxidative Mechanisms
Hayakawa, Sumio; Saito, Kieko; Miyoshi, Noriyuki; Ohishi, Tomokazu; Oishi, Yumiko; Miyoshi, Mamoru; Nakamura, Yoriyuki;
  PDF(new window)
 Abstract
Tea derived from the leaves and buds of Camellia sinensis (Theaceae) is consumed worldwide. Green tea contains various components with specific health-promoting effects, and is believed to exert protective effects against diseases including cancer, diabetes and hepatitis, as well as obesity. Of the various tea components, the polyphenol catechins have been the subject of extensive investigation and among the catechins, (-)-epigallocatechin gallate has the strongest bioactivity in most cases. Our research group has postulated that hepatocyte nuclear factor-, sterol regulatory element-binding proteins, and tumor necrosis factor- are targets of green tea constituents including (-)-epigallocatechin gallate for their anti-diabetes, anti-obesity, and anti-hepatitis effects, respectively. Published papers were reviewed to determine whether the observed changes in these factors can be correlated with anti-cancer effects of green tea. Two major action mechanisms of (-)-epigallocatechin gallate have been proposed; one associated with its anti-oxidative properties and the other with its pro-oxidative activity. When reactive oxygen species are assumed to be involved, our findings that (-)-epigallocatechin gallate downregulated hepatocyte nuclear factor-, sterol regulatory element-binding proteins, and tumor necrosis factor- may explain the anti-cancer effect of green tea as well. However, further studies are required to elucidate which determinant directs (-)-epigallocatechin gallate action as an anti-oxidant or a pro-oxidant for favorable activity.
 Keywords
Green tea;catechin;epigallocatechin gallate;cancer;reactive oxygen species;
 Language
English
 Cited by
1.
Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity, Journal of Immunology Research, 2016, 2016, 2314-7156, 1  crossref(new windwow)
2.
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges, Antioxidants, 2017, 6, 2, 26  crossref(new windwow)
 References
1.
Abe K, Ijiri M, Suzuki T, et al (2005). Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed Res, 26, 187-92. crossref(new window)

2.
Aw TY (1999). Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr, 70, 557-65. crossref(new window)

3.
Babu PV, Liu D, Gilbert ER (2013). Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem, 24, 1777-89. crossref(new window)

4.
Beltz LA, Bayer DK, Moss AL, et al (2006). Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem, 6, 389-406. crossref(new window)

5.
Bogdanski P, Suliburska J, Szulinska M, et al (2012). Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res, 32, 421-7. crossref(new window)

6.
Chen KH, Li PC, Lin WH, et al (2011). Depression by a green tea extract of alcohol-induced oxidative stress and lipogenesis in rat liver. Biosci Biotechnol Biochem, 75, 1668-76. crossref(new window)

7.
Choudhari SK, Chaudhary M, Bagde S, et al (2013). Nitric oxide and cancer: a review. World J Surg Oncol, 11, 118. crossref(new window)

8.
Collins QF, Liu HY, Pi J, et al (2007). Epigallocatechin-3- gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem, 282, 30143-9. crossref(new window)

9.
Gabitova L, Gorin A, Astsaturov I (2014). Molecular pathways: sterols and receptor signaling in cancer. Clin Cancer Res, 20, 28-34. crossref(new window)

10.
Guo D, Bell EH, Mischel P, et al (2014). Targeting SREBP-1- driven lipid metabolism to treat cancer. Curr Pharm Des, 20, 2619-26. crossref(new window)

11.
Huang WC, Li X, Liu J, et al (2012). Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res, 10, 133-42. crossref(new window)

12.
Hwang JT, Ha J, Park IJ, et al (2007). Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett, 247, 115-21. crossref(new window)

13.
Iso H, Date C, Wakai K, et al (2006). The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med, 144, 554-62. crossref(new window)

14.
Jokinen E, Koivunen JP (2015). MEK and PI3K inhibition in solid tumors: rationale and evidence to date. Ther Adv Med Oncol, 7, 170-80. crossref(new window)

15.
Kanadzu M, Lu Y, Morimoto K (2006). Dual function of (--)-epigallocatechin gallate (EGCG) in healthy human lymphocytes. Cancer Lett, 241, 250-5. crossref(new window)

16.
Khan N, Mukhtar H (2010). Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev, 29, 435-45. crossref(new window)

17.
Khan N, Mukhtar H (2013). Tea and health: studies in humans. Curr Pharm Des, 19, 6141-7. crossref(new window)

18.
Koyama Y, Abe K, Sano Y, et al (2004). Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med, 70, 1100-2. crossref(new window)

19.
Lee IT, Yang CM (2013). Inflammatory signalings involved in airway and pulmonary diseases. Mediators Inflamm, 2013, 791231.

20.
Lee MH, Han DW, Hyon SH, et al (2011). Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-kappaB. Apoptosis, 16, 75-85. crossref(new window)

21.
Lee MS, Kim CT, Kim Y (2009). Green tea (-)-epigallocatechin- 3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab, 54, 151-7. crossref(new window)

22.
Li C, Yang W, Zhang J, et al (2014). SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci, 15, 7124-38. crossref(new window)

23.
Li L, Steinauer KK, Dirks AJ, et al (2003). Radiation-induced cyclooxygenase 2 up-regulation is dependent on redox status in prostate cancer cells. Radiat Res, 160, 617-21. crossref(new window)

24.
Li P, Wu M, Wang J, et al (2015). NAC selectively inhibit cancer telomerase activity: A higher redox homeostasis threshold exists in cancer cells. Redox Biol, 8, 91-7.

25.
Li X, Chen YT, Hu P, et al (2014b). Fatostatin displays high antitumor activity in prostate cancer by blocking SREBPregulated metabolic pathways and androgen receptor signaling. Mol Cancer Ther, 13, 855-66. crossref(new window)

26.
Li X, Wu JB, Li Q, et al (2016). SREBP-2 promotes stem celllike properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget, 7, 12869-84. crossref(new window)

27.
Lin KI, Lee SH, Narayanan R, et al (1995). Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol, 131, 1149-61. crossref(new window)

28.
Liu HW, Chan YC, Wang MF, et al (2015). Dietary (-)-epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated mouse. J Agric Food Chem, 63, 8407-17. crossref(new window)

29.
Maeda-Yamamoto M, Suzuki N, Sawai Y, et al (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem, 51, 1858-63. crossref(new window)

30.
Miyoshi N, Pervin M, Suzuki T, et al (2015). Green tea catechins for well-being and therapy: prospects and opportunities. Botanics: Targets Therapy, 5, 85-96.

31.
Motoshima H, Goldstein BJ, Igata M, et al (2006). AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol, 574, 63-71. crossref(new window)

32.
Park IJ, Hwang JT, Kim YM, et al (2006). Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells. Ann N Y Acad Sci, 1091, 102-9. crossref(new window)

33.
Punathil T, Tollefsbol TO, Katiyar SK (2008). EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun, 375, 162-7. crossref(new window)

34.
Saeki K, Kobayashi N, Inazawa Y, et al (2002). Oxidationtriggered c-Jun N-terminal kinase (JNK) and p38 mitogenactivated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3- gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J, 368, 705-20. crossref(new window)

35.
Sakagami H, Satoh K (1997). Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res, 17, 221-4.

36.
Santamarina AB, Oliveira JL, Silva FP, et al (2015). Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High- Fat Diet. PLoS One, 10, 141227.

37.
Sazuka M, Itoi T, Suzuki Y, et al (1996). Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci Biotechnol Biochem, 60, 1317-9. crossref(new window)

38.
Schwartz B, Algamas-Dimantov A, Hertz R, et al (2009). Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4alpha. Int J Cancer, 124, 1081-9. crossref(new window)

39.
Sharma R, Tepas JJ, 3rd (2010). Microecology, intestinal epithelial barrier and necrotizing enterocolitis. Pediatr Surg Int, 26, 11-21. crossref(new window)

40.
Shrestha S, Ehlers SJ, Lee JY, et al (2009). Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr, 139, 640-5. crossref(new window)

41.
Singh BN, Shankar S, Srivastava RK (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol, 82, 1807-21. crossref(new window)

42.
Steinberg GR, Kemp BE (2009). AMPK in Health and Disease. Physiol Rev, 89, 1025-78. crossref(new window)

43.
Suganuma M, Sueoka E, Sueoka N, et al (2000). Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. Biofactors, 13, 67-72. crossref(new window)

44.
Suzuki Y, Miyoshi N, Miyoshi M (2012). Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci, 88, 88-101. crossref(new window)

45.
Tachibana H (2011). Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci, 87, 66-80. crossref(new window)

46.
Tsuneki H, Ishizuka M, Terasawa M, et al (2004). Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol, 4, 18. crossref(new window)

47.
Uchiyama Y, Suzuki T, Mochizuki K, et al (2013). Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats. J Agric Food Chem, 61, 11410-7. crossref(new window)

48.
Waltner-Law ME, Wang XL, Law BK, et al (2002). Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem, 277, 34933-40. crossref(new window)

49.
Wang S, Moustaid-Moussa N, Chen L, et al (2014). Novel insights of dietary polyphenols and obesity. J Nutr Biochem, 25, 1-18. crossref(new window)

50.
Weber LW, Boll M, Stampfl A (2004). Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol, 10, 3081-7. crossref(new window)

51.
Yang CS, Wang H (2011). Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res, 55, 819-31. crossref(new window)

52.
Yang CS, Wang X, Lu G, et al (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer, 9, 429-39. crossref(new window)

53.
Yang CS, Zhang J, Zhang L, et al (2016). Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res, 60, 160-74. crossref(new window)

54.
Yasui K, Paeng N, Miyoshi N, et al (2012). Effects of a catechinfree fraction derived from green tea on gene expression of enzymes related to lipid metabolism in the mouse liver. Biomed Res, 33, 9-13. crossref(new window)

55.
Yasui K, Tanabe H, Okada N, et al (2010). Effects of catechinrich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells. Biomed Res, 31, 183-9. crossref(new window)